Pradaxa Most Dangerous Drug of 2011, Report
The controversial blood-thinning drug Pradaxa is reportedly the medication with the most reports of serious or fatal adverse reactions in 2011.
The controversial blood-thinning drug Pradaxa is reportedly the medication with the most reports of serious or fatal adverse reactions in 2011.
A new lawsuit alleges drug manufacturer Pfizer marketed the antidepressant Zoloft to pregnant women without revealing the risk of it potentially causing birth defects.
Bayer continues to shell out settlement compensation to those affected by allegedly serious blood clotting complications suffered as a result of Yaz and Yasmine use.
The FDA has ordered GlaskoSmithKline to add the risk of potentially fatal heart arrhythmia to the warning label of chemotherapy side effect treatment drug Zofran.
A new study has once again shown rare atypical femoral fractures in women share a link with the osteoporosis drug Fosamax, a drug taken to improve bone density.
A new Canadian study of 115,000 patients treated with the diabetes drug confirmed Actos can double the risk of bladder cancer.
A Pradaxa RE-LY study was conducted prior to FDA approval, but critics claimed it was flawed.
FDA has ordered Yaz and Yasmin to clearly state the risk of blood clots on their warning labels.
Sales of Pradaxa continue to climb steadily despite mounting reports of adverse, sometimes fatal bleeding events.
Additional warning labels have been added to Propecia and Proscar to warn consumers of dangerous side effects.